Efficacy, safety and single-cell analysis of neoadjuvant immunochemotherapy in locally advanced oral squamous cell carcinoma: a phase II trial
Abstract The clinical activity of neoadjuvant immunochemotherapy (NAIC) for treating locally advanced oral squamous cell carcinoma (LA-OSCC) remains uncertain. This single-arm, phase II trial (ChiCTR2200066119) tested 2 cycles of NAIC with camrelizumab plus nab-paclitaxel and cisplatin in LA-OSCC pa...
Saved in:
| Main Authors: | Zhongzheng Xiang, Xiaoyuan Wei, Zhuoyuan Zhang, Yueyang Tang, Linyan Chen, Chenfeng Tan, Yuanyuan Zeng, Jun Wang, Guile Zhao, Zelei Dai, Mingmin He, Ningyue Xu, Chunjie Li, Yi Li, Lei Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-59004-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oncologic outcomes following neoadjuvant immunochemotherapy in locally advanced oral squamous cell carcinoma
by: Gang Li, et al.
Published: (2025-05-01) -
Neoadjuvant immunochemotherapy versus neoadjuvant immunoradiotherapy in locally advanced oral squamous cell carcinoma
by: Gaofeng Ding, et al.
Published: (2025-05-01) -
Single-cell sequencing reveals tumor microenvironment features associated with the response to neoadjuvant immunochemotherapy in oral squamous cell carcinoma
by: Pu-Gen An, et al.
Published: (2025-03-01) -
Neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma: a clinical retrospective study
by: Jiazhen Chen, et al.
Published: (2025-08-01) -
Development and validation of a postoperative risk model for esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy
by: Hai Zhang, et al.
Published: (2025-08-01)